Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence.

NCT01226264 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT01226264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence.
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2010
Completion date
April 30, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffusion-weighted mri, recurrence, uterine cervical cancer